On Mar 10, 2022 Maxwell Biosciences closed a Seed round and raised $10,800,000 from DecentraNet, Joseph Ventures, Keiretsu Forum, Star Lake Bioventures, featuring lead investors DecentraNet.

About the company: Maxwell Biosciences is located at United States, North America.
“Leading research scientists developing next generation virucidal
anti-infective drugs that act directly on the structure of a virus, unlike
current antivirals.”

Company website: http://www.maxwellbiosciences.com